KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹20 Cr | ₹41 Cr | ₹21 Cr | ₹42 Cr | ₹116 Cr |
What is the latest Contingent Liabilities ratio of KOPRAN ?
Year | Contingent Liabilities |
---|---|
Mar2023 | ₹20 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹21 Cr |
Mar2020 | ₹42 Cr |
Mar2019 | ₹116 Cr |
How is Contingent Liabilities of KOPRAN Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹20 Cr | -51.22 | |
Mar2022 | ₹41 Cr | 93.30 | |
Mar2021 | ₹21 Cr | -49.30 | |
Mar2020 | ₹42 Cr | -64.07 | |
Mar2019 | ₹116 Cr | - |
Compare Contingent Liabilities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,145.2 Cr | -8.9% | -11.3% | 64.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.9% | -6.6% | 58.8% | Stock Analytics | |
CIPLA | ₹112,058.0 Cr | -1% | -5.6% | 54.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.9% | 2.2% | 27.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,845.0 Cr | -2.2% | 6.2% | 21.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 2.8% | -0.6% | 96.2% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -8.9% |
-11.3% |
64.4% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses